image
Karyopharm Therapeutics Inc. KPTI
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 7.54
-5.16 %
$ 63.5 M
Market Cap
-0.54
P/E
BALANCE SHEET
164 M ASSETS
-31.62%
Growth Rates
1Year -31.62%
3Years -18.64%
5Years -11.03%
7Years -1.31%
10Years -2.89%
350 M LIABILITIES
-6.96%
Growth Rates
1Year -6.96%
3Years -3.09%
5Years 7.40%
7Years 31.76%
10Years 38.45%
-186 M EQUITY
-36.57%
Growth Rates
1Year -36.57%
3Years -32.66%
5Years -36.49%
7Years -13.57%
10Years -6.63%
BALANCE SHEET DECOMPOSITION
Balance Sheet Karyopharm Therapeutics Inc.
image
Current Assets 156 M
Cash & Short-Term Investments 109 M
Receivables 30.8 M
Other Current Assets 17 M
Non-Current Assets 7.93 M
Long-Term Investments 0
PP&E 6.28 M
Other Non-Current Assets 1.64 M
Current Liabilities 92.3 M
Accounts Payable 5.11 M
Short-Term Debt 876 K
Other Current Liabilities 86.3 M
Non-Current Liabilities 258 M
Long-Term Debt 99.5 M
Other Non-Current Liabilities 159 M

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 62.5 52.2 135.2 190.5 85.9 128.9 118.0 69.0 49.7 58.4 150.6 156.0 0.4 6.5
Short Term Investments 46.2 139.2 142.8 38.2 163.3 133.1 210.2 77.5 79.9 117.3 55.1 0 0 0
Receivables 30.8 27.0 47.1 22.5 12.9 7.9 0 0 0 0 0 0 0 0
Inventory 4.7 3.0 4.2 4.1 2.6 0.3 0 0 0 0 0 0 0 0
Other Current Assets 12.3 12.5 20.9 20.4 11.8 8.4 12.8 3.7 4.2 3.9 4.1 4.0 0.6 0.4
Total Current Assets 156.5 233.9 326.8 258.1 289.5 273.7 334.6 148.4 131.6 177.6 207.8 158.0 1.0 6.9
PP&E 6.3 4.9 7.4 1.6 2.2 3.0 3.9 2.2 2.8 3.5 2.8 0.2 0.3 0.3
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0.6 0.6 24.2 2.0 2.0 29.4 45.4 33.9 8.7 0 0 0
Other Long Term Assets 1.6 1.6 23.4 44.9 (2.9) 16.2 0.7 0.3 0.5 0.5 1.2 30 K 30 K 30 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 164.4 240.4 358.2 305.3 313.1 295.0 341.2 180.3 180.4 215.4 220.3 158.2 1.3 7.2
LIABILITIES
Accounts Payable 5.1 3.1 2.8 1.6 4.5 1.0 4.3 5.7 4.8 3.8 6.3 1.7 1.1 1.1
Short Term Debt 0.9 3.3 5.7 4.6 3.8 3.3 0 0 0 0 0 0 0 0
Other Current Liabilities 86.3 63.0 57.4 67.5 51.6 39.7 33.2 21.9 11.7 11.3 6.0 1.5 0.8 0.8
Total Current Liabilities 92.3 69.5 65.9 73.7 0.3 46.4 46.9 49.5 16.5 15.1 12.3 2.9 1.9 2.1
Long Term Debt 99.5 173.7 176.2 178.3 129.2 123.1 102.7 0 0 0 0 0 0 0
Deferred Tax Income 0 0 (132.7) (133.0) (73.1) 73.6 (93.5) 0 0 0 0 0 0 0
Other Liabilities 158.7 133.5 132.7 133.0 73.1 0 3.9 1.4 1.7 0 1.2 (0.4) 27.3 17.8
Total Liabilities 350.4 376.6 374.8 385.0 262.5 245.2 158.0 50.8 18.1 17.1 13.5 3.3 29.2 19.9
EQUITY
Common Stock 13 K 12 K 12 K 8 K 7 K 7 K 6 K 5 K 4 K 4 K 3 K 3 K 0 0
Retained Earnings (1 563.5) (1 487.0) (1 343.9) (1 178.6) (1 069.6) (873.3) (673.7) (495.3) (366.1) (256.5) (138.3) (62.6) (28.6) (12.7)
Other Accumulative Comprehensive Income/Loss (0.4) (0.2) (0.6) 0.2 0.5 37 K (0.2) (0.2) (0.3) (0.3) 29 K (0.3) (0.2) 84 K
Total Equity (186.0) (136.2) (16.7) (79.7) 50.5 49.8 183.2 129.5 162.2 198.4 206.8 154.9 (27.9) (12.7)
Total Liabilities and Equity 164.4 240.4 358.2 305.3 313.1 295.0 341.2 180.3 180.4 215.4 220.3 158.2 1.3 7.2
SHARES OUTSTANDING
Common Shares Outstanding 121.9 114.2 81.9 75.2 72.0 62.0 56.8 45.9 37.5 35.6 31.1 6.1 2.4 1.0